Is it 30 or 29. I know it's a small difference but you think they could keep it consistent.
GSK had a strong quarter revenue wise and if our market share is improving, then putting two and two together things are looking positive. Big question is how the cost reductions are going???
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable